Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure

Tatsuya Maruhashi1, Junko Soga1, Noritaka Fujimura1

  • 1From the Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences (T.M., J.S., N.F., N.I., S.M., Y.I., A.I., M.K., T.M., N.O., S.K., S.M., H.H., T.H., Y.K.) and Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine (Y.A., F.B.M.Y., K.N., Y.H.), Hiroshima University, Japan; Department of Gastroenterology and Metabolism, Biomedical Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan (K.C.); Division of Regeneration and Medicine, Hiroshima University Hospital, Japan (K.N., A.N., Y.H.); Department of Rehabilitation, Faculty of General Rehabilitation, Hiroshima International University, Japan (C.G.); Department of Cardiology, Tokyo Medical University, Japan (H.T., A.Y., T.K.); Division of Biomedical Engineering, National Defense Medical College Research Institute, Tokorozawa, Japan (B.T.); Cardiovascular Medicine, University of Leicester, United Kingdom (T.S.); Cardiovascular Division, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan (T.I.); Department of Clinical Pharmacology and Therapeutics, University of the Ryukyu School of Medicine, Okinawa, Japan (S.U.); Clinical Research Support Center, Faculty of Medicine, The University of Tokyo, Japan (T.Y.); Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Japan (T.F.); Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan (T.I.); Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan (S.K.); Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology, Yamagata University School of Medicine, Japan (K.W.); Department of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, Japan (Y.T.); Department of Medical Education and Population-Based Medicine, Postgraduate School of Medicine, Wakayama Medical University, Japan (T.H.); Department of Cardiovascular Medicine, Institute of Health Biosciences, The University of Tokushima Graduate School, Japan (M.S.); Department of General Medicine, Shimane University Faculty of Medicine, Izumo, Japan (Y.I.); Department of Cardiovascular and Renal Medicine, Saga University, Japan (K.N.); Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan (K.M.); The Third Department of Internal Medicine, University of the Ryukyus, Okinawa, Japan (Y.O.); Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan (T.F.); Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan (H.I.); and Faculty of Fukuoka Medical Technology, Teikyo University, Japan (H.I.).

Insights

Antihypertensive drug treatment may mask the relationship between high blood pressure and endothelial dysfunction. Even with controlled blood pressure, treated patients show impaired endothelial function compared to untreated individuals.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Physiology

Background:

  • Hypertension is a significant risk factor for cardiovascular disease, often linked to endothelial dysfunction.
  • Endothelial function, assessed via flow-mediated vasodilation (FMD), is crucial for vascular health.
  • The impact of antihypertensive treatment on the blood pressure-endothelial function relationship remains unclear.

Purpose of the Study:

  • To investigate whether antihypertensive treatment status influences the association between blood pressure and endothelial function.
  • To compare endothelial function in treated hypertensive patients versus antihypertensive drug-naive subjects across different blood pressure levels.

Main Methods:

  • Cross-sectional study involving 2297 participants (1822 drug-naive, 475 treated hypertensive patients).
  • Measurement of flow-mediated vasodilation (FMD) to assess endothelial function.
  • Statistical analysis, including propensity score matching, to compare FMD between groups and its association with systolic blood pressure.

Main Results:

  • In drug-naive subjects, higher systolic blood pressure was significantly associated with lower FMD (P<0.001).
  • In treated hypertensive patients, no significant relationship was observed between systolic blood pressure and FMD (P=0.77).
  • Endothelial dysfunction was more prevalent in treated hypertensive patients than in untreated subjects across all systolic blood pressure categories.

Conclusions:

  • Antihypertensive treatment may attenuate the direct correlation between systolic blood pressure and endothelial function.
  • Endothelial function appears impaired in treated hypertensive patients, irrespective of their achieved blood pressure levels.
  • Further research is needed to understand the long-term vascular effects of antihypertensive therapies on endothelial health.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
644
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.5K